Healthequity Inc (NASDAQ: HQY) Lose -19.90%, Marking A Loss For Bears.

In the latest trading session, 1.91 million Healthequity Inc (NASDAQ:HQY) shares changed hands as the company’s beta touched 0.43. With the company’s most recent per share price at $81.44 changed hands at -$20.23 or -19.90% at last look, the market valuation stands at $7.06B. HQY’s current price is a discount, trading about -41.93% off its 52-week high of $115.59. The share price had its 52-week low at $65.01, which suggests the last value was 20.17% up since then. When we look at Healthequity Inc’s average trading volume, we note the 10-day average is 0.95 million shares, with the 3-month average coming to 781.10K.

Analysts gave the Healthequity Inc (HQY) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.40. If we narrow down to specifics, the data shows that 0 out of 11 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended HQY as a Hold, 10 felt it is a Buy and 0 rated the stock as Underweight. Healthequity Inc’s EPS for the current quarter is expected to be 0.84.

Healthequity Inc (NASDAQ:HQY) trade information

Instantly HQY was in red as seen in intraday trades today. With action -14.97%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -15.12%, with the 5-day performance at -14.97% in the red. However, in the 30-day time frame, Healthequity Inc (NASDAQ:HQY) is -28.08% down. Looking at the short shares, we see there were 4.31 million shares sold at short interest cover period of 6.08 days.

The consensus price target for the stock as assigned by Wall Street analysts is 112, meaning bulls need an upside of 27.29% from its recent market value. According to analyst projections, HQY’s forecast low is 112 with 112 as the target high. To hit the forecast high, the stock’s price needs a -37.52% plunge from its current level, while the stock would need to soar -37.52% for it to hit the projected low.

Healthequity Inc (HQY) estimates and forecasts

Year-over-year growth is forecast to reach 8.27% up from the last financial year.

Consensus estimates given by 7 financial analysts project the company’s revenue in the current quarter to hit an average of 322.39M. 7 analysts are of the opinion that Healthequity Inc’s revenue for the current quarter will be 320.87M. The company’s revenue for the corresponding quarters a year ago was 287.6M and 299.93M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 12.10%. The estimates for the next quarter sales put growth at 6.98%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -11.29%. The 2025 estimates are for Healthequity Inc earnings to increase by 18.40%, but the outlook for the next 5-year period is at 19.66% per year.

Healthequity Inc (NASDAQ:HQY)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 2.14% of Healthequity Inc shares while 105.76% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 108.07%. There are 105.76% institutions holding the Healthequity Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 12.4196% of the shares, roughly 10.74 million HQY shares worth $925.74 million.

VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 10.2062% or 8.83 million shares worth $760.76 million as of 2024-06-30.

Among Mutual Funds, the top two as of Jan 31, 2025 were iShares Core S&P Midcap ETF and Vanguard Total Stock Market Index Fund. With 2.85 shares estimated at $231.18 million under it, the former controlled 3.29% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 3.17% of the shares, roughly 2.74 shares worth around $222.62 million.